Pharmacokinetics and brain entry of alaptide, a novel nootropic agent, in mice, rats and rabbits

J Pharm Pharmacol. 1991 Dec;43(12):874-6. doi: 10.1111/j.2042-7158.1991.tb03200.x.

Abstract

Pharmacokinetics of a novel nootropic agent, alaptide, have been examined in plasma and brain of mice, rats and rabbits following an intravenous dose (1 mg kg-1). First-order equilibration rate constants between plasma and brain (kBO) were calculated by a two-compartment model with a linked compartment (brain). Brain alaptide equilibrates rapidly with the central compartment in mice and rats due to the high kBO/beta ratio. In rabbits the equilibration is much slower (kBO/beta approximately 1). Partition coefficients between brain and plasma calculated from areas under the brain and plasma concentration-time curves, are 0.479, 0.549 and 0.864, in mice, rats and rabbits, respectively.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Brain / metabolism
  • Chinchilla
  • Chromatography, Thin Layer
  • In Vitro Techniques
  • Male
  • Mice
  • Models, Biological
  • Neuropeptides / administration & dosage
  • Neuropeptides / blood
  • Neuropeptides / pharmacokinetics*
  • Neuropeptides / urine
  • Peptides, Cyclic / administration & dosage
  • Peptides, Cyclic / blood
  • Peptides, Cyclic / pharmacokinetics*
  • Peptides, Cyclic / urine
  • Protein Binding
  • Psychotropic Drugs / administration & dosage
  • Psychotropic Drugs / blood
  • Psychotropic Drugs / pharmacokinetics*
  • Psychotropic Drugs / urine
  • Rabbits
  • Rats
  • Rats, Inbred Strains
  • Serum Albumin, Bovine

Substances

  • Neuropeptides
  • Peptides, Cyclic
  • Psychotropic Drugs
  • Serum Albumin, Bovine
  • cyclo(alanine-(1-amino-1-cyclopentane)carbonyl)